A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain
Public ClinicalTrials.gov record NCT00833040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Placebo-Controlled, Crossover Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 Compared to Placebo in the Treatment of Cancer Breakthrough Pain
Study identification
- NCT ID
- NCT00833040
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Talphera, Inc
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- Feb 28, 2010
- Completion
- Feb 28, 2010
- Last update posted
- Dec 31, 2014
2009 – 2010
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trials and Research Associates | Montebello | California | 90640 | — |
| Florida Institute of Medical Research | Jacksonville | Florida | 32257 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33805 | — |
| Sarasota Pain Medicine Research | Sarasota | Florida | 34238 | — |
| Lovelace Scientific Resources | Venice | Florida | 34292 | — |
| Drug Studies America, Inc. | Marietta | Georgia | 30060 | — |
| Better Health Clinical Research, Inc. | Newnan | Georgia | 30265 | — |
| International Clinical Research Institute | Overland Park | Kansas | 66211 | — |
| Willis-Knighton Pain Management Center | Shreveport | Louisiana | 71103 | — |
| Four Seasons Hospice & Palliative Care | Flat Rock | North Carolina | 28731 | — |
| Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Research Concepts Ltd | Houston | Texas | 77024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00833040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 31, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00833040 live on ClinicalTrials.gov.